SRSusanna Ranta

Susanna Ranta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Susanna Ranta has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2002
      • Vol. 118  (15) , 1551-8

    [Northern epilepsy and the gene error behind it].

    by Susanna Ranta, Aune Hirvasniemi, Riitta Herva, Matti Haltia, Anna-Elina Lehesjoki


  • Positional cloning and characterisation of the human DLGAP2 gene and its exclusion in progressive epilepsy with mental retardation

    by Susanna Ranta, Yonghui Zhang, Barbara Ross, Elina Takkunen, Aune Hirvasniemi, Albert de la Chapelle, T Conrad Gilliam, Anna-Elina Lehesjoki

    In search of the gene for progressive epilepsy with mental retardation (EPMR) we identified DLGAP2, the human homolog of the gene encoding the rat PSD-95/SAP90-associated protein-2 (Dlgap2). We extended the transcript in both the 5′ and 3′ directions and characterised the genomic structure of the approximately 10 kb gene. Sequence comparisons of human DLGAP2 cDNA sequences obtained from human testis and brain cDNA libraries with homologous rat genes suggest alternative splicing in the 5′ end of the gene. The 5′ coding sequence of the testis cDNA is complete, whereas based on homology with the rat gene 103 bp of coding sequence may still be missing in the 5′ end of the DLGAP2 brain transcript. DLGAP2 was excluded as the gene responsible for EPMR


  • The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8

    by Susanna Ranta, Yonghui Zhang, Barbara Ross, Liina Lonka, Elina Takkunen, Anne Messer, Julie Sharp, Ruth Wheeler, Kenro Kusumi, Sara Mole, et al.

    The neuronal ceroid lipofuscinoses (NCLs) are a genetically heterogeneous group of progressive neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigment in various tissues1. Progressive epilepsy with mental retardation (EPMR, MIM 600143) was recently recognized as a new NCL subtype2 (CLN8). It is an autosomal recessive disorder characterized by onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation3. Here we report the positional cloning of a novel gene, CLN8, which is mutated in EPMR. It encodes a putative transmembrane protein. EPMR patients were homozygous for a missense mutation (70C→G, R24G) that was not found in homozygosity in 433 controls. We also cloned the mouse Cln8 sequence. It displays 82% nucleotide identity with CLN8, conservation of the codon harbouring the human mutation and is localized to the same region as the motor neuron degeneration mouse, mnd, a naturally occurring mouse NCL (ref. 4). In mnd/mnd mice, we identified a homozygous 1-bp insertion (267-268insC, codon 90) predicting a frameshift and a truncated protein. Our data demonstrate that mutations in these orthologous genes underlie NCL phenotypes in human and mouse, and represent the first description of the molecular basis of a naturally occurring animal model for NCL.